Literature DB >> 15668999

Identification of grass pollen allergens by two-dimensional gel electrophoresis and serological screening.

Valeria Corti1, Angela Cattaneo, Angela Bachi, Renato E Rossi, Giorgio Monasterolo, Clara Paolucci, Samuele E Burastero, Massimo Alessio.   

Abstract

Approximately 50% of allergic patients are sensitized against grass pollen allergens. The characterization of specific immunoglobulin E (IgE) reactivity to allergen components in pollen-allergic patients is fundamental for clinical diagnosis and for immunotherapy. Complex allergen extracts are commonly used in diagnostic tests as well as in immunotherapy preparations, but their composition in single allergenic molecules is only partially known. Diagnostic tests which utilize recombinant or immuno-purified allergens have been made available in clinical practice. They allow to obtain specific profiles of IgE reactivity, but the panel of available molecules is far from complete. Here, we used a proteomic approach in order to detect grass allergens from a natural protein extract. A five-grass pollen extract used for diagnosis and immunotherapy was resolved by two dimensional gel electrophoresis (2-DE), and assayed with 9 sera from pollen-allergic patients whose sensitization profile was dissected by using IgE reactivity to recombinant allergens. 2-DE immunoreactivity patterns were matched with IgE reactivity to identify protein spots as candidate allergens. Identity was confirmed by mass spectrometry analysis. We identified 6 out of 8 expected clinically relevant allergens in the natural grass extract. Moreover, we identified different molecular isoforms of single allergens, thus obtaining a more detailed profile of IgE reactivity. Some discrepancies in protein isoform profile and sera immunoreactivity between recombinant and native allergen 5 from Phleum pratense were observed and a new putative allergen was described. The proteomic approach applied to the analysis of a natural allergen allows the comprehensive evaluation of the sensitization profile of allergic patients and the identification of new allergens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668999     DOI: 10.1002/pmic.200401038

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  6 in total

1.  Epitope mapping and structural analysis of the anti-Der p 1 monoclonal antibody: insight into therapeutic potential.

Authors:  Yu-Chou Dai; Woei-Jer Chuang; Kaw-Yan Chua; Chi-Chang Shieh; Jiu-Yao Wang
Journal:  J Mol Med (Berl)       Date:  2011-05-13       Impact factor: 4.599

Review 2.  Structural characterization of pollen allergens.

Authors:  Petra Verdino
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

3.  Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders.

Authors:  Daniela Privitera; Valeria Corti; Massimo Alessio; Maria Antonietta Volontè; Antonietta Volontè; Vito Lampasona; Giancarlo Comi; Gianvito Martino; Diego Franciotta; Roberto Furlan; Raffaella Fazio
Journal:  Neurol Sci       Date:  2012-03-06       Impact factor: 3.307

4.  Proteins from Tuber magnatum Pico fruiting bodies naturally grown in different areas of Italy.

Authors:  Federico Vita; Valentina Lucarotti; Emanuele Alpi; Raffaella Balestrini; Antonietta Mello; Angela Bachi; Massimo Alessio; Amedeo Alpi
Journal:  Proteome Sci       Date:  2013-02-01       Impact factor: 2.480

Review 5.  Pollen proteomics: from stress physiology to developmental priming.

Authors:  Palak Chaturvedi; Arindam Ghatak; Wolfram Weckwerth
Journal:  Plant Reprod       Date:  2016-06-08       Impact factor: 3.767

6.  The Identification and Characterization of Immunoreactive Fungal Proteins Recognized by Sera from Zimbabweans Sensitized to Fungi.

Authors:  Lorraine Tsitsi Pfavayi; Richard Burchmore; Elopy Nimele Sibanda; Stephen Baker; Mark Woolhouse; Takafira Mduluza; Francisca Mutapi
Journal:  Int Arch Allergy Immunol       Date:  2022-05-18       Impact factor: 3.767

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.